These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32144493)

  • 21. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure.
    Ng TM; Cao DX; Patel KA; Wong YM; Prasad M; Lou M; Elkayam U
    Cardiology; 2014; 128(4):333-42. PubMed ID: 24942293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization.
    Luk A; Groarke JD; Desai AS; Mahmood SS; Gopal DM; Joyce E; Shah SP; Lindenfeld J; Stevenson L; Lakdawala NK
    Am Heart J; 2018 Sep; 203():95-100. PubMed ID: 29907406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF).
    Ng TMH; Grazette LP; Fong MW; Yoon AJ; Lou M; Kuo A; Upadhyay RY; Han EE; Mehra A; Elkayam U
    ESC Heart Fail; 2020 Aug; 7(4):1927-1934. PubMed ID: 32543020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
    Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
    Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
    J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
    Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
    ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit.
    Brinkley DM; Burpee LJ; Chaudhry SP; Smallwood JA; Lindenfeld J; Lakdawala NK; Desai AS; Stevenson LW
    J Card Fail; 2018 Jun; 24(6):349-354. PubMed ID: 29410227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretic response in acute heart failure-an analysis from ASCEND-HF.
    ter Maaten JM; Dunning AM; Valente MA; Damman K; Ezekowitz JA; Califf RM; Starling RC; van der Meer P; O'Connor CM; Schulte PJ; Testani JM; Hernandez AF; Tang WH; Voors AA
    Am Heart J; 2015 Aug; 170(2):313-21. PubMed ID: 26299229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.
    Vargo DL; Brater DC; Rudy DW; Swan SK
    J Am Soc Nephrol; 1996 Jul; 7(7):1032-7. PubMed ID: 8829118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
    Martens P; Chen HH; Verbrugge FH; Testani JT; Mullens W; Tang WHW
    Eur J Heart Fail; 2022 Oct; 24(10):1978-1987. PubMed ID: 36054180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
    Damman K; Ng Kam Chuen MJ; MacFadyen RJ; Lip GY; Gaze D; Collinson PO; Hillege HL; van Oeveren W; Voors AA; van Veldhuisen DJ
    J Am Coll Cardiol; 2011 May; 57(22):2233-41. PubMed ID: 21616283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
    Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
    ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia.
    Omar HR; Guglin M
    Heart Lung Circ; 2020 Feb; 29(2):233-241. PubMed ID: 30745014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
    Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H
    Clin Res Cardiol; 2013 Oct; 102(10):745-53. PubMed ID: 23839288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.
    De Vecchis R; Ariano C; Esposito C; Giasi A; Cioppa C; Cantatrione S
    Minerva Cardioangiol; 2012 Oct; 60(5):517-29. PubMed ID: 23018431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyponatremia in Acute Heart Failure in Relation to Hematocrit Levels: Clinical Relevance and Prognostic Implication.
    Ruocco G; Verbrugge FH; Nuti R; Palazzuoli A
    Cardiorenal Med; 2018; 8(4):259-270. PubMed ID: 30045026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
    Sica D; Oren RM; Gottwald MD; Mills RM;
    Clin Cardiol; 2010 Jun; 33(6):330-6. PubMed ID: 20556802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.